3D Medicines, Inc. (HK:1244) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3D Medicines Inc. has successfully passed all proposed resolutions during their Annual General Meeting on June 28, 2024, with overwhelming shareholder support. Key approvals included the adoption of audited financial statements, re-election of directors, and appointment of a new company auditor. Shareholders also granted the board mandates to issue additional shares and repurchase shares, enhancing the company’s financial flexibility.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.